Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis

Objective:. This study aimed to compare operative time, blood loss, and transfusion requirement in patients receiving a high tranexamic acid (TXA) dose of greater than 10 mg/kg versus those receiving a low dose of 10 mg/kg or less. Methods:. PubMed, Cochrane Central, and Embase were queried to perfo...

Full description

Bibliographic Details
Main Authors: Devon B. O’Donnell, BS, Sima Vazquez, MS, Jacob D. Greisman, BA, Anaz Uddin, MS, Gillian Graifman, BS, Jose F. Dominguez, MD, Elizabeth Zellner, MD, Carrie R. Muh, MD
Format: Article
Language:English
Published: Wolters Kluwer 2022-10-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004526
_version_ 1817978655044796416
author Devon B. O’Donnell, BS
Sima Vazquez, MS
Jacob D. Greisman, BA
Anaz Uddin, MS
Gillian Graifman, BS
Jose F. Dominguez, MD
Elizabeth Zellner, MD
Carrie R. Muh, MD
author_facet Devon B. O’Donnell, BS
Sima Vazquez, MS
Jacob D. Greisman, BA
Anaz Uddin, MS
Gillian Graifman, BS
Jose F. Dominguez, MD
Elizabeth Zellner, MD
Carrie R. Muh, MD
author_sort Devon B. O’Donnell, BS
collection DOAJ
description Objective:. This study aimed to compare operative time, blood loss, and transfusion requirement in patients receiving a high tranexamic acid (TXA) dose of greater than 10 mg/kg versus those receiving a low dose of 10 mg/kg or less. Methods:. PubMed, Cochrane Central, and Embase were queried to perform a systematic review with meta-analysis. Studies reporting outcomes of TXA use in craniosynostosis surgery were included. TXA dosing, operative time, blood loss, and transfusion requirement were the primary outcomes studied. Other variables studied included age and types of craniosynostosis. Results:. In total, 398 individuals in the included articles received TXA for craniosynostosis surgery. TXA loading doses ranged from 10 mg/kg to 50 mg/kg. Overall, administration of TXA was not associated with changes in operative time, but was associated with decreased blood loss and transfusion requirement on meta-analysis. Comparison of high dose TXA (>10 mg/kg) versus low dose (10 mg/kg or less) showed no statistical differences in changes in operative time, blood loss, or transfusion requirement. Conclusions:. Overall, TXA reduced blood loss and transfusion requirement in patients undergoing surgery for craniosynostosis. There was no difference in outcomes between high dose and low dose regimens amongst those receiving TXA. Low dose TXA appears adequate to achieve clinical efficacy with a low adverse event rate.
first_indexed 2024-04-13T22:32:53Z
format Article
id doaj.art-e01a668e20fb4db299899de0d85d11d4
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-04-13T22:32:53Z
publishDate 2022-10-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-e01a668e20fb4db299899de0d85d11d42022-12-22T02:26:53ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742022-10-011010e452610.1097/GOX.0000000000004526202210000-00029Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysisDevon B. O’Donnell, BS0Sima Vazquez, MS1Jacob D. Greisman, BA2Anaz Uddin, MS3Gillian Graifman, BS4Jose F. Dominguez, MD5Elizabeth Zellner, MD6Carrie R. Muh, MD7From the * Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.From the * Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.From the * Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.From the * Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.From the * Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.From the * Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.† Department of Surgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.From the * Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, N.Y.Objective:. This study aimed to compare operative time, blood loss, and transfusion requirement in patients receiving a high tranexamic acid (TXA) dose of greater than 10 mg/kg versus those receiving a low dose of 10 mg/kg or less. Methods:. PubMed, Cochrane Central, and Embase were queried to perform a systematic review with meta-analysis. Studies reporting outcomes of TXA use in craniosynostosis surgery were included. TXA dosing, operative time, blood loss, and transfusion requirement were the primary outcomes studied. Other variables studied included age and types of craniosynostosis. Results:. In total, 398 individuals in the included articles received TXA for craniosynostosis surgery. TXA loading doses ranged from 10 mg/kg to 50 mg/kg. Overall, administration of TXA was not associated with changes in operative time, but was associated with decreased blood loss and transfusion requirement on meta-analysis. Comparison of high dose TXA (>10 mg/kg) versus low dose (10 mg/kg or less) showed no statistical differences in changes in operative time, blood loss, or transfusion requirement. Conclusions:. Overall, TXA reduced blood loss and transfusion requirement in patients undergoing surgery for craniosynostosis. There was no difference in outcomes between high dose and low dose regimens amongst those receiving TXA. Low dose TXA appears adequate to achieve clinical efficacy with a low adverse event rate.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004526
spellingShingle Devon B. O’Donnell, BS
Sima Vazquez, MS
Jacob D. Greisman, BA
Anaz Uddin, MS
Gillian Graifman, BS
Jose F. Dominguez, MD
Elizabeth Zellner, MD
Carrie R. Muh, MD
Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis
Plastic and Reconstructive Surgery, Global Open
title Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis
title_full Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis
title_fullStr Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis
title_full_unstemmed Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis
title_short Tranexamic Acid Dosing in Craniosynostosis Surgery: A Systematic Review with Meta-analysis
title_sort tranexamic acid dosing in craniosynostosis surgery a systematic review with meta analysis
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004526
work_keys_str_mv AT devonbodonnellbs tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis
AT simavazquezms tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis
AT jacobdgreismanba tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis
AT anazuddinms tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis
AT gilliangraifmanbs tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis
AT josefdominguezmd tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis
AT elizabethzellnermd tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis
AT carriermuhmd tranexamicaciddosingincraniosynostosissurgeryasystematicreviewwithmetaanalysis